Associated Content, 25 Jun 2009, Gary Davis
The Singapore Economic Development Board (EBD) is moving quickly. The EBD is part of a plan to launch a state-of-the-art vaccine plant. In addition to the overall development of the plant, EBD has added $20 million to a fund to teach people about green issues as well as public health
GlaxoSmithKline is moving quickly to manufacture vaccines at a primary manufacturing site. This underscores GlaxoSmithKline's commitment to Singapore and further is the company's largest investment in Asia.
Read More
